Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 41 pseudogene (KRT41P) is part of the human type I hair keratin gene cluster but is inactivated in humans by a single base-pair substitution introducing a premature stop codon in exon 4, leading to loss of function[1][7][2]. While its ortholog encodes a functional hair keratin protein in nonhuman primates such as chimpanzees and gorillas, the human version is the product of a recent mutational event and does not encode a protein[1][7]. Its inactivation may have contributed to differences in hair structure between humans and great apes, though specific functional consequences are unknown[1]. KRT41P is catalogued and named according to the consensus keratin pseudogene nomenclature[2][7]. It is not a molecular therapeutic target, nor does it participate in pathways or processes of clinical interest in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 41 pseudogene (KRT41P).